These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 35027066)
1. Sex-specific contribution of lipid accumulation product and cardiometabolic index in the identification of nonalcoholic fatty liver disease among Chinese adults. Liu Y; Wang W Lipids Health Dis; 2022 Jan; 21(1):8. PubMed ID: 35027066 [TBL] [Abstract][Full Text] [Related]
2. Validity of cardiometabolic index, lipid accumulation product, and body adiposity index in predicting the risk of hypertension in Chinese population. Wang H; Chen Y; Sun G; Jia P; Qian H; Sun Y Postgrad Med; 2018 Apr; 130(3):325-333. PubMed ID: 29478365 [TBL] [Abstract][Full Text] [Related]
3. Gender-specific contribution of cardiometabolic index and lipid accumulation product to left ventricular geometry change in general population of rural China. Wang H; Sun Y; Li Z; Guo X; Chen S; Ye N; Tian Y; Zhang L BMC Cardiovasc Disord; 2018 Apr; 18(1):62. PubMed ID: 29631555 [TBL] [Abstract][Full Text] [Related]
4. Sex-Specific Contribution of Cardiometabolic Index in Predicting Metabolic Dysfunction-Associated Fatty Liver Disease: Insights from a General Population. Gu D; Lu Y; Xu B; Tang X Diabetes Metab Syndr Obes; 2023; 16():3871-3883. PubMed ID: 38054037 [TBL] [Abstract][Full Text] [Related]
5. Body adiposity index, lipid accumulation product, and cardiometabolic index reveal the contribution of adiposity phenotypes in the risk of hyperuricemia among Chinese rural population. Wang H; Sun Y; Wang S; Qian H; Jia P; Chen Y; Li Z; Zhang L Clin Rheumatol; 2018 Aug; 37(8):2221-2231. PubMed ID: 29770928 [TBL] [Abstract][Full Text] [Related]
6. Cardiometabolic Index (CMI), Lipid Accumulation Products (LAP), Waist Triglyceride Index (WTI) and the risk of acute pancreatitis: a prospective study in adults of North China. Sun Q; Ren Q; Du L; Chen S; Wu S; Zhang B; Wang B Lipids Health Dis; 2023 Nov; 22(1):190. PubMed ID: 37946249 [TBL] [Abstract][Full Text] [Related]
7. Waist-to-height ratio, an optimal anthropometric indicator for metabolic dysfunction associated fatty liver disease in the Western Chinese male population. Cai J; Lin C; Lai S; Liu Y; Liang M; Qin Y; Liang X; Tan A; Gao Y; Lu Z; Wu C; Huang S; Yang X; Zhang H; Kuang J; Mo Z Lipids Health Dis; 2021 Oct; 20(1):145. PubMed ID: 34706716 [TBL] [Abstract][Full Text] [Related]
8. Lipid accumulation product (LAP) index for the diagnosis of nonalcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis. Ebrahimi M; Seyedi SA; Nabipoorashrafi SA; Rabizadeh S; Sarzaeim M; Yadegar A; Mohammadi F; Bahri RA; Pakravan P; Shafiekhani P; Nakhjavani M; Esteghamati A Lipids Health Dis; 2023 Mar; 22(1):41. PubMed ID: 36922815 [TBL] [Abstract][Full Text] [Related]
9. The association between healthy eating index-2015 with anthropometric, cardiometabolic and hepatic indices among patients with non-alcoholic fatty liver disease. Hosseini SA; Shayesteh AA; Hashemi SJ; Rahimi Z; Saki N; Bavi Behbahani H; Cheraghian B; Alipour M BMC Gastroenterol; 2024 May; 24(1):159. PubMed ID: 38724894 [TBL] [Abstract][Full Text] [Related]
10. Lipid accumulation product is a powerful tool to predict non-alcoholic fatty liver disease in Chinese adults. Dai H; Wang W; Chen R; Chen Z; Lu Y; Yuan H Nutr Metab (Lond); 2017; 14():49. PubMed ID: 28775758 [TBL] [Abstract][Full Text] [Related]
11. Lipid accumulation product is a valid predictor of hepatic steatosis and nonalcoholic fatty liver disease. Huang Q; Tan X; Wu Q; Zhao H; Chen H; Yu X; Wang J; Huang X; Huang Y; Wei J; Wu F; Zhu H; Wang L Biomark Med; 2024 Feb; 18(3):123-135. PubMed ID: 38456353 [No Abstract] [Full Text] [Related]
12. Visceral adiposity index for the diagnosis of nonalcoholic fatty liver disease in premenopausal women with and without polycystic ovary syndrome. Vassilatou E; Lafoyianni S; Vassiliadi DA; Ioannidis D; Paschou SA; Mizamtsidi M; Panagou M; Vryonidou A Maturitas; 2018 Oct; 116():1-7. PubMed ID: 30244768 [TBL] [Abstract][Full Text] [Related]
13. Comparison of several blood lipid-related indexes in the screening of non-alcoholic fatty liver disease in women: a cross-sectional study in the Pearl River Delta region of southern China. Wang J; Su Z; Feng Y; Xi R; Liu J; Wang P BMC Gastroenterol; 2021 Dec; 21(1):482. PubMed ID: 34923965 [TBL] [Abstract][Full Text] [Related]
14. Association of adiposity indicators with cardiometabolic multimorbidity risk in hypertensive patients: a large cross-sectional study. Dong T; Lin W; Zhou Q; Yang Y; Liu X; Chen J; Liu H; Zhang C Front Endocrinol (Lausanne); 2024; 15():1302296. PubMed ID: 38577567 [TBL] [Abstract][Full Text] [Related]
15. Sex differences in the association between adipose insulin resistance and non-alcoholic fatty liver disease in Chinese adults. Wei Y; Liu J; Wang G; Wang Y Biol Sex Differ; 2023 Oct; 14(1):69. PubMed ID: 37814297 [TBL] [Abstract][Full Text] [Related]
16. Association between the cardiometabolic index and NAFLD and fibrosis. Yan L; Hu X; Wu S; Cui C; Zhao S Sci Rep; 2024 Jun; 14(1):13194. PubMed ID: 38851771 [TBL] [Abstract][Full Text] [Related]
17. The lipid accumulation product is a powerful tool to diagnose metabolic dysfunction-associated fatty liver disease in the United States adults. Li H; Zhang Y; Luo H; Lin R Front Endocrinol (Lausanne); 2022; 13():977625. PubMed ID: 36407325 [TBL] [Abstract][Full Text] [Related]
18. Validation of simple indexes for nonalcoholic fatty liver disease in western China: a retrospective cross-sectional study. Zhu J; He M; Zhang Y; Li T; Liu Y; Xu Z; Chen W Endocr J; 2018 Mar; 65(3):373-381. PubMed ID: 29434074 [TBL] [Abstract][Full Text] [Related]
19. Associations Between Abdominal Obesity Indices and Nonalcoholic Fatty Liver Disease: Chinese Visceral Adiposity Index. Chen X; Shi F; Xiao J; Huang F; Cheng F; Wang L; Ju Y; Zhou Y; Jia H Front Endocrinol (Lausanne); 2022; 13():831960. PubMed ID: 35360076 [TBL] [Abstract][Full Text] [Related]
20. Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease. Motamed N; Sohrabi M; Ajdarkosh H; Hemmasi G; Maadi M; Sayeedian FS; Pirzad R; Abedi K; Aghapour S; Fallahnezhad M; Zamani F World J Gastroenterol; 2016 Mar; 22(10):3023-30. PubMed ID: 26973398 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]